{"Title": "Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT (Adv Ther, (2016), 33, (1012-1024), 10.1007/s12325-016-0335-4)", "Year": 2016, "Source": "Adv. Ther.", "Volume": "33", "Issue": 9, "Art.No": null, "PageStart": 1677, "PageEnd": 1678, "CitedBy": 0, "DOI": "10.1007/s12325-016-0390-x", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84980021589&origin=inward", "Abstract": "\u00a9 2016, The Author(s).Following publication of the aforementioned article the authors noticed that a sentence had been omitted from the acknowledgements section pertaining to the AstraZeneca development team. The acknowledgements section should read as follows: ACKNOWLEDGMENTS: We thank all the patients who took part in the study, colleagues within the Sarah Cannon Research Institute UK site who cared for these patients, and Bartley O\u2019Connor of Sqeeler Limited for the IT platform used during this pilot study. We also thank David Peters of Sequoia Medical Communications Ltd, who provided medical writing assistance funded by AstraZeneca, and colleagues within the AstraZeneca development team (most notably A\u00b0 sa Strom, Stephanie Roberts, Christelle Gendrin, Paul Bonnet, Shamma Iqbal, and Shirley Spratt). This study was sponsored by AstraZeneca. The article processing charges and open access fee for this publication were funded by AstraZeneca. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. Open Access. This article is distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.", "AuthorKeywords": null, "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84980021589", "SubjectAreas": [["Pharmacology (medical)", "MEDI", "2736"]], "AuthorData": {"56789468200": {"Name": "Hughes A.", "AuthorID": "56789468200", "AffiliationID": "60003771, 60120601", "AffiliationName": "Manchester Cancer Research Centre, University of Manchester"}, "56911970700": {"Name": "Landers D.", "AuthorID": "56911970700", "AffiliationID": "60004219", "AffiliationName": "AstraZeneca"}, "57204026724": {"Name": "Shah S.", "AuthorID": "57204026724", "AffiliationID": "60004219", "AffiliationName": "AstraZeneca"}, "57204026025": {"Name": "Mahal A.", "AuthorID": "57204026025", "AffiliationID": "60004219", "AffiliationName": "AstraZeneca"}, "57204026605": {"Name": "Royle J.", "AuthorID": "57204026605", "AffiliationID": "60120602, 60003771", "AffiliationName": "Cancer Research UK Manchester Institute, The University of Manchester"}, "6603300234": {"Name": "Arkenau H.T.", "AuthorID": "6603300234", "AffiliationID": "60022148", "AffiliationName": "University College London"}, "57204025708": {"Name": "Simmons M.", "AuthorID": "57204025708", "AffiliationID": "109697477", "AffiliationName": "Sarah Cannon Research Institute"}, "37091105800": {"Name": "Lemech C.", "AuthorID": "37091105800", "AffiliationID": "60022148", "AffiliationName": "University College London"}, "57190110830": {"Name": "Stephens R.", "AuthorID": "57190110830", "AffiliationID": "117624171", "AffiliationName": "Consumer Forum, National Cancer Research Institute"}}}